2m 2m 2m 2m 2m 2m 2m
ABEONA THERAP (ABEO)
NASDAQ
$5.57+$0.15 (+2.77%)
Price as of Sep 11, 2026 7:30 PM EDT- $309.7MMarket Cap
- -15.79%1-Year Change
- BiotechnologyIndustry
ABEONA THERAP (ABEO)
$5.57+$0.15 (+2.77%)
ABEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.42 | ||
Change | -$0.07 (-1.19%) | ||
Open | $5.55 | ||
High | $5.66 | ||
Low | $5.40 | ||
Previous Close | $5.48 | ||
Volume | 1,598,025 | ||
30-Day Average Volume | 1,578,271 | ||
1-Week Change | -9.75% | ||
1-Month Change | -26.82% | ||
1-Year Change | -15.79% | ||
3-Year Change | 23.35% | ||
5-Year Change | -83.21% | ||
Fundamentals | |||
Shares Outstanding | 57.2M | ||
Total Assets | $179.5M | ||
Market Cap | $309.7M | ||
Enterprise Value | $268.4M | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | -$20.2M | ||
Free Cash Flow | -$18.0M | ||
EBIT | -$19.6M | ||
EBITDA | -$18.9M | ||
Net Working Capital | $139.8M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 198 | ||
P/B | 2 | ||
P/E | -15 | ||
PEG | 1 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 07/05/2022 | ||
Earnings & Revenue